BIOMAT Database Logo BIOMAT Database Logo

Relationship between no-reflow phenomenon and serotonin levels in patients with acute ST-elevation myocardial infarction who underwent primary percutaneous intervention. 2010

Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
Department of Cardiology, Erciyes University, School of Medicine, Kayseri, Turkey.

OBJECTIVE Our aim was to investigate the effects of serotonin, which is a severe vasoconstrictor agent, on the occurrence of no-reflow phenomenon. METHODS In this cross-sectional controlled study, 40 patients, admitted to our clinic with chest pain in the first 12 hours and underwent primary percutaneous coronary intervention because of acute myocardial infarction were enrolled. Patients with TIMI 0 grade basal flow and normal post-procedure flow were included in group 1 and patients with flow grade TIMI < or =were enrolled in group 2. To measure the serotonin levels, blood samples were collected from the coronary ostium before the procedure. RESULTS In group 1, there were 25 patients (20 males, 5 females) and the mean age was 58+/-11 years; in group 2 there were 15 patients (13 males, 2 females) and the mean age was 62+/-8 years. The mean serotonin level in platelet in group 1 was 476+/-208 ng/109 platelet and in group 2-542+/-273 ng/109 platelet. The difference was not statistically significant (p=0.39). When we compared the serum serotonin levels, it was 41.4+/-40.8 ng/ml for group 1, but 66.7+/-45.7 ng/ml for group 2. Although the serum serotonin levels were higher in group 2, the difference was not statistically significant (p=0.07). CONCLUSIONS There was no effect of serotonin level in the development of no-reflow, in patients to whom primary coronary percutaneous intervention was applied.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002637 Chest Pain Pressure, burning, or numbness in the chest. Precordial Catch,Precordial Catch Syndrome,Texidor's Twinge,Chest Pains,Pain, Chest,Pains, Chest,Syndrome, Precordial Catch,Texidor Twinge
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional

Related Publications

Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
May 2020, The international journal of cardiovascular imaging,
Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
Comment on "The relationship between atherogenic index of plasma and no‑reflow in patients with acute ST‑segment elevation myocardial infarction who underwent primary percutaneous coronary intervention".
May 2020, The international journal of cardiovascular imaging,
Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
December 2015, Coronary artery disease,
Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
November 2018, Journal of clinical laboratory analysis,
Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
August 2016, Angiology,
Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
Relationship between Hemoglobin Concentration at Admission with the Incidence of No-Reflow Phenomenon and In-Hospital Mortality in Acute Myocardial Infarction with Elevation of ST Segments in Patients who underwent Primary Percutaneous Coronary Intervention.
June 2023, The International journal of angiology : official publication of the International College of Angiology, Inc,
Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.
October 2016, Angiology,
Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
June 2019, Coronary artery disease,
Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
June 2020, Medicine,
Ramazan Topsakal, and Mehmet G Kaya, and Ekrem Karakaya, and Ozgür Günebakmaz, and Ali Doğan, and M Tuğrul Inanç, and Bahadir Sarli, and Ibrahim Ozdoğru, and Ali Ergin
Relationship between Fragmented QRS and NT-proBNP in Patients with ST Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
January 2018, Acta Cardiologica Sinica,
Copied contents to your clipboard!